| |
|
|
|
Redhill Biopharma Ltd. - Americ
|
|
9.11 -0.14 (-1.51%) |
10/23/2017 4:00pm |
|
Open: |
9.32 |
Pre close: |
9.25 |
Target:
|
11.92
|
|
High: |
9.33 |
Low: |
9.00 |
Resistance:
|
10.21
11.25
|
|
Volume: |
57,935 |
Market Cap: |
156.35M |
Support:
|
8.52
7.09
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.94
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
9.42 |
Signal(12,26,9): |
0.04  |
|
MA(100): |
9.00 |
Stochastic Oscillator |
%K(14,3):
|
23.59 |
|
MA(250): |
9.82 |
%D(3): |
14.72 |
|
Average Volume(K) |
3-Month: |
9135
|
52-Week |
High:
|
13.30 |
|
10-Days: |
6190 |
Low: |
8.16 |
|
RSI |
RSI(14):
|
49.27 |
Change(%): |
-32.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.460 |
Return on Equity (ttm) |
-75.5 |
Shares Out. (M) |
17.00 |
|
EPS Est. Current Year |
-2.390 |
Return on Assets (ttm) |
-43.4 |
Shares Float (M) |
15.78 |
|
EPS Est. Next Year |
-0.540 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.53 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
48200.0 |
% Held by Institutions |
10.93 |
|
Forward EPS |
-1.998 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
214 |
|
Book Value (p.s.) |
2.840 |
EBITDA (p.s.) |
-2.414 |
P/E |
-3.70 |
|
Sales Per Share |
0.034 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.21 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-37.59 |
P/S |
265.64 |
|
Operating Margin |
-7047.51 |
Levered Free Cash Flow
(M) |
-22.52 |
P/CF |
-4.12 |
|
|
|
|
|
|
|
